期刊文献+

食管内照射支架的研制及临床应用的初步结果 被引量:35

Esophageal intraluminal irradiation stent: primary results of development and clinical application(
原文传递
导出
摘要 目的 探索食管内照射支架研制、临床使用的可行性、安全性及初步疗效。方法 选择合适的覆膜或裸食管支架 ,于支架外周按一定的规律固定上特制的可容纳放射粒子的鞘 ,根据患者病变的范围通过治疗计划系统 (treatmentplansystem ,TPS)计算出放射粒子的剂量 ,将放射粒子装进上述鞘内即制成食管内照射支架。临床选择 15例食管癌患者 ,临床分级为Ⅱ~Ⅳ级 ,将放疗支架植入到患者病变食管内并进行临床随访。结果  15例患者内照射支架均释放到位 ,释放过程顺利 ,释放过程中未出现放射粒子脱落现象 ;全身γ射线显像 (ECT)复查未发现非靶器官显像 ;患者全身一般状况明显好转 ,血象和免疫指标亦未见明显变化 ,未出现如食管穿孔、出血等并发症 ;13例术后 1个月CT复查提示病灶的厚度较术前变簿 ,2例变大 ,3例随访近 8个月 ,CT复查病变厚度较术前明显变薄 ,胃镜检查并活检提示支架捆绑粒子部位肿瘤明显缩小 ,活检未发现肿瘤细胞生长。结论 食管内照射支架临床使用是安全、可行、有效的 。 Objective To investigate the feasibility, safety, primary clinical effectiveness of development, and clinical application of esophageal intraluminal irradiation stent.Methods The proper stent was first chosen, and the specially made sheath involving radiated particles was fixed outside the stent according to some rules. Based on the size of the tumor focus, the radiated dose of the particles was computed through TPS system, and the particles were put into the sheath, then the esophageal intraluminal irradiation stent was finished. Esophageal intraluminal irradiation stents were placed in 15 patients with esophageal cancer of Ⅱ-Ⅳ grade esophageal carcinoma, and the clinical effectiveness was observed.Results(The finished) stents were put into the sites of 15 diseased esophagus, and the released process was successful without dropping off of the particles. No radiated source leakage was discovered through the ECT examination. The patients’ general conditions improved obviously, neither hematological nor immunological examination changed obviously, nor complications such as esophageal perforation or hematorrhea. In (13 patients,) the focus thickness was thinner markedly after 1 month through CT examination, and 2 of them became lager. 3 of the patients were followed for 8 months, and the focus thickness was thinner obviously through CT examination. On the sites of fixed particles, the tumors obviously drew back and no cancer cells showed growing through gastroscopy and biopsy. Conclusion Esophageal intraluminal irradiation stent is safe, feasible, and effective, and its long-term clinical effectiveness still needs further follow-up observation and comparative research.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2004年第9期916-920,共5页 Chinese Journal of Radiology
基金 江苏省卫生厅医学科技发展基金 (H2 0 0 3 43 )
关键词 食管 内照射 支架 患者 临床应用 放射 CT复查 提示 过程 粒子 Esophageal neoplasms Iodine radioisotopes Stents Brachytherapy Radiology, interventional
  • 相关文献

参考文献9

  • 1Fritz P, Wannenmacher M. Radiotherapy in the multimodal treatment of esophageal carcinoma:a review.Strahlenther Onkol (German),1997,173:295-308.
  • 2Okawa T, Dokiya T, Nishio N, et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys, 1999, 45: 623-628.
  • 3La Face B, Micheletti E, Baroncelli G, et al. Intracavitary brachytherapy in esophageal neoplasms. Experience at the Radiology Institute of Brescial. Radiol Med (Torino),1997,93:607-612.
  • 4Kenji N, Shogo Y, Masato H, et al. Radiation therapy for superficial esophageal cancer:a comparison of radiotherapy methods. Int J Radiat Oncol Biol Phys, 2001, 50: 639-644.
  • 5Kikuchi Y. Study on clinical application of multiple fractions per day radiation therapy with concomitant boost technique for esophageal cancer(Review). Hokkaido Igaku Zasshi(Japanese), 1993,68:537-543.
  • 6Mohiuddin M, Rosato F, Barbot D, et al. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys, 1992,23:305-311.
  • 7Ragde H, Blasko JC, Grimm PD,et al. Brachytherapy for clinically localized prostate cancer: results at 7-and 8-year follow-up. Semin Surg Oncol, 1997,13:438-443.
  • 8Martinez-Monge R, Nag S, Nieroda CA,et al. Iodine-125 brachytherapy in the treatment of colorectal adenocarcinoma metastatic to the liver. Cancer, 1999, 85: 1218-1225.
  • 9Videtic GM, Gaspar LE, Zamorano L,et al. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys, 1999,45:687-692.

同被引文献287

引证文献35

二级引证文献210

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部